1 janv. 2003 - First targeted drugs for lung cancer attack "EGFR" receptor

Description:

FDA approves two new targeted treatments for lung cancer, gefitinib and erlotinib.

Ajouté au bande de temps:

16 nov. 2018

0

0

254

Cancer Dates

Date: